Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yeol Hong Kim"'
Autor:
Ju Won Kim, Ah Reum Lim, Ji Yoon Lee, June Young Lee, Soohyeon Lee, Yoon Ji Choi, Yeol Hong Kim, Kyong Hwa Park
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Purpose Chemotherapy-induced nausea and vomiting (CINV) is a common adverse events in cancer patients and can negatively affect their quality of life (QoL). This study aimed to evaluate the clinical efficacy of an electric massage chair (EMC
Externí odkaz:
https://doaj.org/article/a9c6d46a0975427a8a39d0f2ca612f12
Autor:
Soon Young Kwon, Kyong Hwa Park, Kwang-Yoon Jung, Yeol Hong Kim, Yong Park, In S. Kim, Chul Yong Kim, Nam Joon Lee, Sang Won Shin, Jun Suk Kim, Seung Kuk Baek, Dae Sik Kim
Publikováno v:
Onkologie. 35:673-682
Background: The purpose of this study was to test the hypothesis that the immunohistochemical expression of ERCC1 and RASSF1A would predict both response to and survival after docetaxel and cisplatin combination chemotherapy in inoperable or recurren
Autor:
Yeol Hong Kim, Jun Suk Kim, Min Kyoung Kim, Myung Ah Lee, Kyung Hee Lee, Hoon Kyo Kim, Seock-Ah Im, Ho Yeong Lim, Hong Suk Song, Dae Young Zang, Heung Moon Chang, Bong Seog Kim, Baek Yeol Ryoo, Jae Yong Cho
Publikováno v:
Cancer Chemotherapy and Pharmacology. 64:317-325
Gemcitabine is the only drug approved for single-agent therapy in advanced pancreatic carcinoma (APC). Gemcitabine-based combination chemotherapy has not yet shown promising results.This multicenter phase II study enrolled previously untreated patien
Publikováno v:
Cancer Genetics and Cytogenetics. 152:153-157
Chromosomal aberrations were investigated in 48 Korean nonsmall cell carcinomas of the lung (NSCLC), by degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization. These included 16 adenocarcinomas, 27 squamous cell